One of the most recent studies out of Greece involved researchers looking into a vaporized weed formula with 13% CBD and 9% THC, and its effects on 69 patients with multiple sclerosis. The participants had varying symptoms, including muscle spasticity, bladder dysfunction, and disability progressions, all of which were analyzed at baseline levels to be evaluated again at three then six months. According to the researchers, “Significant improvement was observed across all outcome assessments,” after the patients were given vaporized weed.
Members of Outlawz have said for years that they mixed some of Tupac Shakur’s ashes…
State and local police made at least 218,152 marijuana-related arrests in 2025, including 200,960 for…
Three days in Philadelphia, September 25 to 27, with a free record-clearing clinic and a…
Four decades after its Amsterdam beginnings, Barney’s Farm is marking the milestone with new markets,…
Gallup’s new numbers hold a small, awkward pattern: the Americans most convinced cannabis is bad…
The FDA is seeking outside data and analytics services to better understand how people use…